Table 3.
Pregnancy monitoring outcome post messenger RNA (mRNA) COVID-19 vaccination of pregnant healthcare personnel in general hospitals in Penang, Malaysia.
| Parameters observed during pregnancy | n (%) |
|---|---|
| Second trimester (14–27 weeks of pregnancy) (n = 121) | |
| Estimated birth weight, mean (SD), kg | 0.6 (0.12) |
| Fetal heart rate, mean (SD), beats per minute (rpm) | 148 (6.3) |
| Maximum vertical pocket (MVP) | |
| Normal | 121 (100) |
| Abnormal (oligohydramnios or polyhydramnios) | 0 |
| Detection of anomalies | |
| No | 121 (100) |
| Yes | 0 |
| Detection of intrauterine growth restriction (IUGR) | |
| No | 121 (100) |
| Yes | 0 |
| Third trimester (28 and onwards weeks of pregnancy; n = 120) | |
| Estimated birth weight, mean (SD), kg | 2.3 (0.52) |
| Fetal heart rate, mean (SD), rate per minute (rpm) | 149 (6.0) |
| Maximum vertical pocket (MVP) | |
| Normal | 120 (100) |
| Abnormal (oligohydramnios or polyhydramnios) | 0(0) |
| Detection of anomalies | |
| No | 120 (100) |
| Yes | 0(0) |
| Detection of intrauterine growth restriction (IUGR) | |
| No | 120 (100) |
| Yes | 0 (0) |
| Delivery week, median (IQR), weeks (days) | 38 (4) |
| Method of delivery | |
| Spontaneous vaginal delivery (SVD) | 83 (68.6) |
| Cesarean section (C-sec) | 37 (31.4) |